科研级 Bezlotoxumab ( 贝洛托舒单抗 ), Anti-Toxin B Recombinant Antibody, Research Grade Bezlotoxumab
Molecular Name
Bezlotoxumab
Size
1mg, 5mg
CAS Number
1246264-45-8
Isotype
IgG1 Kappa
Clonality
Monoclonal
Concentration
1mg/ml
Source
CHO Cells
Purity
≥95% as determined by SDS-PAGE
Buffer
Supplied in PBS, PH7.5
Target
toxin B[Clostridium difficile]
Sequence
Please contact our sales representative to learn more information about this reagents.
Background
Bezlotoxumab, sold under the brand name Zinplava, is a human monoclonal antibody designed for the prevention of recurrence of Clostridium difficile infections. This drug, along with actoxumab, was developed through Phase II efficacy trials by a partnership between Medarex Inc and MassBiologics of the University of Massachusetts Medical School.